Daniela Faria
23 Papers
35 Citations
Daniela Faria is an academic researcher. The author has contributed to research in topics: Medicine & Rotator cuff. The author has an hindex of 2, co-authored 21 publications.
Chat about Author
Papers
Relevance of ultrasonography in assessing disease activity in patients with idiopathic inflammatory myopathies.
TL;DR: The usefulness of ultrasonography (US) as a monitoring tool iniopathic inflammatory myopathies was evaluated to see if it can be used as a diagnostic tool in IIM.
17
•Journal Article
Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update.
Cátia Duarte,Joana Sousa-Neves,Ana Filipa Águeda,Pedro Ribeiro,Alexandra Daniel,Gisela Eugénio,Sofia Serra,Filipe Araújo,Anabela Barcelos,Barcelos Filipe,Miguel Bernardes,Helena Canhão,Marcos Cerqueira,Susana Capela,Ana Cordeiro,Flávio Costa,Lúcia Costa,Margarida Cruz,Luís Cunha Miranda,Catarina Duarte,Sandra Falcão,Daniela Faria,Ricardo Figueira,João Freitas,Maria João Gonçalves,João Madruga Dias,José António Melo Gomes,Ana Filipa Mourão,Adriano Neto,Filipa Ramos,Sofia Pimenta,Patrícia Pinto,Joaquim Polido-Pereira,Cristina Ponte,João Ramos,Ana M. Rodrigues,Helena Santos,Maria José Santos,Alexandre Sepriano,Candida Silva,José Tavares Costa,Filipa Teixeira,Vitor Hugo Teixeira,Paula Valente,Elsa Vieira-Sousa,Rita Barros,Pedro Abreu,João Eurico Fonseca +47 more
TL;DR: These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion and may be used for guidance of treatment with biological therapies in patients with RA.
•Journal Article
Systemic sclerosis induced by interferon-alfa treatment of melanoma.
TL;DR: A case of a patient who developed systemic sclerosis after treatment of melanoma with interferon alfa-2b, drug rarely implicated in the induction of this disease is described.
6
•Journal Article
Effectiveness of early adalimumab therapy in psoriatic arthritis patients from Reuma.pt - EARLY PsA.
Helena Santos,Mónica Eusébio,Joana Borges,Diana Goncalves,Pedro Avila-Ribeiro,Daniela Faria,Carina Lopes,João Rovisco,Ana Filipa Águeda,P. Nero,Paula Valente,Cravo Ar,Maria José Santos +12 more
TL;DR: Early PsA patients had a greater chance of improvement after ADA therapy and better functional outcome, and achieved PsARC response more rapidly than late PsA, and in this cohort, comedication with csDMARDs was beneficial over 2 years.
6
•Journal Article
Positive affect as a predictor of adherence in patients with Rheumatoid Arthritis.
Joana Lúcia Lima Correia Rodrigues,Daniela Faria,Joana Sousa Neves,Joana Silva,Daniela Peixoto,Sérgio Alcino,Maria Carmo Afonso,Filipa Teixeira,Rosa Marina Afonso,Henrique Pereira,Soraia Azevedo,José Tavares Costa +11 more
TL;DR: Positive affect seems to be an important determinant of therapeutic adherence in RA patients, and a relevant role of psychosocial aspects in therapeutic compliance and outcome is suggested, which should alert physicians to the need of an holistic approach of the patient.
5